IT1275802B1 - Composizione di interferone - Google Patents

Composizione di interferone

Info

Publication number
IT1275802B1
IT1275802B1 IT95MI002202A ITMI952202A IT1275802B1 IT 1275802 B1 IT1275802 B1 IT 1275802B1 IT 95MI002202 A IT95MI002202 A IT 95MI002202A IT MI952202 A ITMI952202 A IT MI952202A IT 1275802 B1 IT1275802 B1 IT 1275802B1
Authority
IT
Italy
Prior art keywords
interferone
composition
interferone composition
Prior art date
Application number
IT95MI002202A
Other languages
English (en)
Inventor
Charanjit Rai Behl
Aruna Sudhir Railkar
Navnit Hargovindas Shah
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ITMI952202A0 publication Critical patent/ITMI952202A0/it
Publication of ITMI952202A1 publication Critical patent/ITMI952202A1/it
Application granted granted Critical
Publication of IT1275802B1 publication Critical patent/IT1275802B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT95MI002202A 1994-11-03 1995-10-25 Composizione di interferone IT1275802B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33370294A 1994-11-03 1994-11-03

Publications (3)

Publication Number Publication Date
ITMI952202A0 ITMI952202A0 (it) 1995-10-25
ITMI952202A1 ITMI952202A1 (it) 1997-04-25
IT1275802B1 true IT1275802B1 (it) 1997-10-17

Family

ID=23303915

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI002202A IT1275802B1 (it) 1994-11-03 1995-10-25 Composizione di interferone

Country Status (4)

Country Link
JP (1) JPH08208510A (it)
DE (1) DE19540669A1 (it)
FR (1) FR2726470B1 (it)
IT (1) IT1275802B1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
SK12772003A3 (sk) 2001-04-18 2004-07-07 Prometic Biosciences Inc. Stredne dlhé mastné kyseliny, glyceridy a analógy ako faktory prežitia a aktivácie neutrofilov
DK1592416T3 (da) 2003-02-07 2009-04-20 Prometic Biosciences Inc Fedtsyrer med middel kædelængde, glycerider og analoger som stimulatorer af erythropoiesis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
NL9101176A (nl) * 1991-07-05 1993-02-01 Stork Brabant Bv Zeefdrukinrichting met continue rapportering van roterende sjablonen.
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
JP3418423B2 (ja) * 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物

Also Published As

Publication number Publication date
ITMI952202A0 (it) 1995-10-25
JPH08208510A (ja) 1996-08-13
ITMI952202A1 (it) 1997-04-25
FR2726470B1 (fr) 1999-02-26
DE19540669A1 (de) 1996-05-09
FR2726470A1 (fr) 1996-05-10

Similar Documents

Publication Publication Date Title
DE69526966D1 (de) Hautkräftigende kometische zusammensetzung
DE69506552D1 (de) Seife zusammensetzung
DE69531318D1 (de) Shampoozusammensetzung
BR9509760A (pt) Composto
BR9508844A (pt) Composição oral
BR9508318A (pt) Composição impadora concentrada
BR9506536A (pt) Composição oral
FI954773A (fi) Antihypertriglyserideeminen koostumus
DE69502164D1 (de) Schmierfettzusammensetzung
BR9607058A (pt) Composição
BR9606809A (pt) Composição inseticidamente ativa
DE69512397D1 (de) Wärmehärtende zusammensetzung
BR9508089A (pt) Composição para lavagem de louça
DE69519148D1 (de) Flussmittelzusammensetzung
DE69503738D1 (de) Fotopolymerisierbare Zusammensetzung
PT728814E (pt) Composicao betuminosa
ITMI942089A0 (it) Composizione di carburante
FI972421A0 (fi) Hapettumista ehkäisevät seokset
BR9609903A (pt) ComposiçÃo inseticidamente ativa
ITMI940362A0 (it) Composizione antitosse
BR9509899A (pt) Composição modificadora de sabor
DE69524412D1 (de) Schmierfettzusammensetzung
DE69616374D1 (de) Germizide zusammensetzung
MA23731A1 (fr) Compositions detegentes
BR9607946A (pt) Composição

Legal Events

Date Code Title Description
0001 Granted